[{"address1": "150 N. Radnor Chester Rd.", "address2": "Suite F200", "city": "Radnor", "state": "PA", "zip": "19087", "country": "United States", "phone": "888 378 6240", "website": "https://mineralystx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D.", "age": 46, "title": "Founder & Executive Chairman", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 69333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon  Congleton", "age": 60, "title": "CEO & Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 775775, "exercisedValue": 0, "unexercisedValue": 194101}, {"maxAge": 1, "name": "Mr. Adam Scott Levy", "age": 45, "title": "CFO & Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 655575, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David M. Rodman M.D.", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 726950, "exercisedValue": 0, "unexercisedValue": 1718681}, {"maxAge": 1, "name": "Ms. Cindy  Berejikian", "title": "Executive Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Foster", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  McKean Ph.D.", "title": "Senior Vice President of CMC", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Danielle  Bradbury", "title": "Senior Vice President of Quality Assurance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey N. Fellows", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Ibbitson", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1730073600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.96, "open": 13.79, "dayLow": 13.6, "dayHigh": 13.96, "regularMarketPreviousClose": 13.96, "regularMarketOpen": 13.79, "regularMarketDayLow": 13.6, "regularMarketDayHigh": 13.96, "forwardPE": -4.052941, "volume": 402902, "regularMarketVolume": 402902, "averageVolume": 152309, "averageVolume10days": 112660, "averageDailyVolume10Day": 112660, "bid": 13.68, "ask": 13.84, "bidSize": 100, "askSize": 100, "marketCap": 685233920, "fiftyTwoWeekLow": 5.85, "fiftyTwoWeekHigh": 16.905, "fiftyDayAverage": 12.6174, "twoHundredDayAverage": 12.661, "currency": "USD", "enterpriseValue": 374118592, "floatShares": 23836482, "sharesOutstanding": 49726700, "sharesShort": 1613175, "sharesShortPriorMonth": 1472177, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0324, "heldPercentInsiders": 0.025510002, "heldPercentInstitutions": 1.00624, "shortRatio": 11.47, "shortPercentOfFloat": 0.0475, "bookValue": 5.836, "priceToBook": 2.3612063, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -119671000, "trailingEps": -2.76, "forwardEps": -3.4, "pegRatio": -0.08, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MLYS", "underlyingSymbol": "MLYS", "shortName": "Mineralys Therapeutics, Inc.", "longName": "Mineralys Therapeutics, Inc.", "firstTradeDateEpochUtc": 1676039400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3938497f-b328-3672-a2d9-cbf07921aed8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 13.78, "targetHighPrice": 45.0, "targetLowPrice": 26.0, "targetMeanPrice": 32.5, "targetMedianPrice": 31.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 311115008, "totalCashPerShare": 6.257, "quickRatio": 10.956, "currentRatio": 11.198, "returnOnAssets": -0.27578, "returnOnEquity": -0.41617, "freeCashflow": -52320248, "operatingCashflow": -97297000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-31"}]